BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15302913)

  • 21. Subtle discrepancies of SF2/ASF ESE sequence motif among human tissues: A computational approach.
    Siala O; Rebai A; Baklouti F; Fakhfakh F
    Comput Biol Chem; 2010 Jun; 34(3):203-9. PubMed ID: 20637698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single RNA recognition motif in splicing factor ASF/SF2 directs it to nuclear sites of adenovirus transcription.
    Lindberg A; Gama-Carvalho M; Carmo-Fonseca M; Kreivi JP
    J Gen Virol; 2004 Mar; 85(Pt 3):603-608. PubMed ID: 14993643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional domains of the human splicing factor ASF/SF2.
    Zuo P; Manley JL
    EMBO J; 1993 Dec; 12(12):4727-37. PubMed ID: 8223481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.
    Tacke R; Manley JL
    EMBO J; 1995 Jul; 14(14):3540-51. PubMed ID: 7543047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel SR protein binding site in a cis-regulatory element of HIV-1.
    Suptawiwat O; Boonarkart C; Auewarakul P
    Arch Virol; 2010 Nov; 155(11):1789-95. PubMed ID: 20668893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.
    Cartegni L; Krainer AR
    Nat Genet; 2002 Apr; 30(4):377-84. PubMed ID: 11925564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2/ASF.
    Sanford JR; Coutinho P; Hackett JA; Wang X; Ranahan W; Caceres JF
    PLoS One; 2008 Oct; 3(10):e3369. PubMed ID: 18841201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation.
    Li X; Wang J; Manley JL
    Genes Dev; 2005 Nov; 19(22):2705-14. PubMed ID: 16260492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative splicing of CD200 is regulated by an exonic splicing enhancer and SF2/ASF.
    Chen Z; Ma X; Zhang J; Hu J; Gorczynski RM
    Nucleic Acids Res; 2010 Oct; 38(19):6684-96. PubMed ID: 20558599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human splicing factor ASF/SF2 can specifically recognize pre-mRNA 5' splice sites.
    Zuo P; Manley JL
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3363-7. PubMed ID: 7512732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splicing factor ASF/SF2 and transcription factor PPAR-gamma cooperate to directly regulate transcription of uncoupling protein-3.
    Kim DJ; Oh B; Kim YY
    Biochem Biophys Res Commun; 2009 Jan; 378(4):877-82. PubMed ID: 19073146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2.
    Ngo JC; Chakrabarti S; Ding JH; Velazquez-Dones A; Nolen B; Aubol BE; Adams JA; Fu XD; Ghosh G
    Mol Cell; 2005 Oct; 20(1):77-89. PubMed ID: 16209947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis.
    Verduci L; Simili M; Rizzo M; Mercatanti A; Evangelista M; Mariani L; Rainaldi G; Pitto L
    J Biol Chem; 2010 Dec; 285(50):39551-63. PubMed ID: 20923760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and functional analysis of RNA and TAP binding to SF2/ASF.
    Tintaru AM; Hautbergue GM; Hounslow AM; Hung ML; Lian LY; Craven CJ; Wilson SA
    EMBO Rep; 2007 Aug; 8(8):756-62. PubMed ID: 17668007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arginine methylation controls the subcellular localization and functions of the oncoprotein splicing factor SF2/ASF.
    Sinha R; Allemand E; Zhang Z; Karni R; Myers MP; Krainer AR
    Mol Cell Biol; 2010 Jun; 30(11):2762-74. PubMed ID: 20308322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).
    Sun D; Novotny M; Bulek K; Liu C; Li X; Hamilton T
    Nat Immunol; 2011 Aug; 12(9):853-60. PubMed ID: 21822258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control.
    Sun S; Zhang Z; Sinha R; Karni R; Krainer AR
    Nat Struct Mol Biol; 2010 Mar; 17(3):306-12. PubMed ID: 20139984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The serine/arginine-rich protein SF2/ASF regulates protein sumoylation.
    Pelisch F; Gerez J; Druker J; Schor IE; Muñoz MJ; Risso G; Petrillo E; Westman BJ; Lamond AI; Arzt E; Srebrow A
    Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16119-24. PubMed ID: 20805487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A splicing-independent function of SF2/ASF in microRNA processing.
    Wu H; Sun S; Tu K; Gao Y; Xie B; Krainer AR; Zhu J
    Mol Cell; 2010 Apr; 38(1):67-77. PubMed ID: 20385090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gene encoding the splicing factor SF2/ASF is a proto-oncogene.
    Karni R; de Stanchina E; Lowe SW; Sinha R; Mu D; Krainer AR
    Nat Struct Mol Biol; 2007 Mar; 14(3):185-93. PubMed ID: 17310252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.